- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7373
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Seizures in patients with IDH-mutated lower grade gliomas ; volume:160 ; number:2 ; day:18 ; month:10 ; year:2022 ; pages:403-411 ; date:11.2022
Journal of neuro-oncology ; 160, Heft 2 (18.10.2022), 403-411, 11.2022
- Urheber
-
Carstam, Louise
Rydén, Isabelle
Jakola, Asgeir Store
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11060-022-04158-6
- URN
-
urn:nbn:de:101:1-2023021521301924829876
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Carstam, Louise
- Rydén, Isabelle
- Jakola, Asgeir Store
- SpringerLink (Online service)
Ähnliche Objekte (12)
Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period
Therapies for IDH-Mutant Gliomas
Stalled oligodendrocyte differentiation in IDH-mutant gliomas
Methylation class oligosarcoma may encompass IDH-wildtype gliomas
Lower Grade Gliomas
The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET
ATRX immunostaining predicts IDH and H3F3A status in gliomas
Characteristics of gliomas in patients with somatic IDH mosaicism
Proteomic Exploration of IDH-Mutant Gliomas using Mass Spectrometry
Predicting IDH genotype in gliomas using FET PET radiomics
Longitudinal DNA methylation analysis of adult-type IDH-mutant gliomas
Non-invasive detection of 2-hydroxyglutarate in IDH-mutated gliomas using two-dimensional localized correlation spectroscopy (2D L-COSY) at 7 Tesla
Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period
Therapies for IDH-Mutant Gliomas
Stalled oligodendrocyte differentiation in IDH-mutant gliomas
Methylation class oligosarcoma may encompass IDH-wildtype gliomas
Lower Grade Gliomas
The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET
ATRX immunostaining predicts IDH and H3F3A status in gliomas
Characteristics of gliomas in patients with somatic IDH mosaicism
Proteomic Exploration of IDH-Mutant Gliomas using Mass Spectrometry
Predicting IDH genotype in gliomas using FET PET radiomics
Longitudinal DNA methylation analysis of adult-type IDH-mutant gliomas
Non-invasive detection of 2-hydroxyglutarate in IDH-mutated gliomas using two-dimensional localized correlation spectroscopy (2D L-COSY) at 7 Tesla
Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period
Therapies for IDH-Mutant Gliomas
Stalled oligodendrocyte differentiation in IDH-mutant gliomas
Methylation class oligosarcoma may encompass IDH-wildtype gliomas
Lower Grade Gliomas
The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET
ATRX immunostaining predicts IDH and H3F3A status in gliomas
Characteristics of gliomas in patients with somatic IDH mosaicism
Proteomic Exploration of IDH-Mutant Gliomas using Mass Spectrometry
Predicting IDH genotype in gliomas using FET PET radiomics
Longitudinal DNA methylation analysis of adult-type IDH-mutant gliomas